特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
962966

肝臓病診断の世界市場規模調査:診断技術別(実験室試験、画像診断、内視鏡検査、生検など)、最終用途別(病院、研究所など)および地域予測(2020年~2027年)

Global Liver Disease Diagnostics Market Size study, by Diagnosis Technique (Laboratory Tests, Imaging, Endoscopy, Biopsy and Others), by End-Use (Hospitals, Laboratories and Others) and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
肝臓病診断の世界市場規模調査:診断技術別(実験室試験、画像診断、内視鏡検査、生検など)、最終用途別(病院、研究所など)および地域予測(2020年~2027年)
出版日: 2020年10月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の肝臓病診断の市場規模は2019年に約293億米ドルであり、2020年から2027年の予測期間にわたって6.5%を超える成長率で成長すると予想されています。高齢者人口の増加や急性および慢性肝疾患の有病率の上昇などの要因により、肝臓病診断市場の需要が高まります。たとえば、世界保健機関(WHO)によると、2018年に報告された肝臓がんの新規症例の総数は84万1,080であり、世界中で推定78万1631人が肝臓がんで死亡しました。さらに、大量のアルコール消費の増加による末期肝不全の発生率の増加、肥満の増加は、肝臓の世界の臓器ケアシステムの成長を促進する可能性のある主要な要因です。しかし、厳しい政府規制、薬剤の研究開発にかかる高額な費用、および投薬に関連する副作用は、予測期間中の世界の肝臓病診断市場の成長を抑制する可能性がある要因です。

当レポートでは、肝臓病診断市場を調査し、市場概要、市場の成長要因および阻害要因の分析、診断技術別・最終用途別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の肝臓病診断市場の定義と範囲

第3章 世界の肝臓病診断市場力学

  • 肝臓病診断市場の影響分析(2018-2027)

第4章 世界の肝臓病診断市場業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 世界の肝臓病診断市場:診断技術別

  • 市場スナップショット
  • 世界の肝臓病診断市場-潜在的な分析:診断技術、パフォーマンス別
  • 世界の肝臓病診断市場の推定と診断技術別予測(2017年-2027年)
  • 肝臓病診断市場:サブセグメント分析
    • 実験室試験
    • イメージング
    • 内視鏡検査
    • 生検
    • その他

第6章 世界の肝臓病診断市場:最終用途別

  • 市場スナップショット
  • 世界の肝臓病診断市場-潜在的な分析:最終用途、パフォーマンス別
  • 世界の肝臓病診断市場の推定と最終用途別予測(2017年-2027年)
  • 肝臓病診断市場:サブセグメント分析
    • 病院
    • 研究所
    • その他

第7章 世界の肝臓病診断市場:地域別分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • 中南米スナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Abbott Laboratories
    • F.Hoffmann-La Roche AG
    • Randox Laboratories
    • Boston Scientific Corporation
    • Siemens Healthineers AG
    • BioMerieux
    • Quest Diagnostics
    • Biosino Bio-technology
    • Horiba, Ltd.

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Liver Disease Diagnostics market, report scope
  • TABLE 2. Global Liver Disease Diagnostics market estimates & forecasts by region 2017-2027 (USD Billion)
  • TABLE 3. Global Liver Disease Diagnostics market estimates & forecasts by Diagnosis Technique 2017-2027 (USD Billion)
  • TABLE 4. Global Liver Disease Diagnostics market estimates & forecasts by End-Use 2017-2027 (USD Billion)
  • TABLE 5. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 6. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 19. Global Liver Disease Diagnostics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Global Liver Disease Diagnostics market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. U.S. Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 22. U.S. Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 23. U.S. Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 24. Canada Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 25. Canada Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 26. Canada Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 27. UK Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 28. UK Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 29. UK Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. Germany Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 31. Germany Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 32. Germany Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 33. France Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 34. France Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 35. France Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. Spain Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 37. Spain Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 38. Spain Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. Italy Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 40. Italy Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 41. Italy Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. ROE Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 43. ROE Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. ROE Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 45. China Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 46. China Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 47. China Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. India Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 49. India Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. India Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. Japan Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 52. Japan Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 53. Japan Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Australia Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 55. Australia Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. Australia Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 57. South Korea Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 58. South Korea Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 59. South Korea Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 60. ROPAC Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 61. ROPAC Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 62. ROPAC Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 63. Brazil Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 64. Brazil Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 65. Brazil Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 66. Mexico Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 67. Mexico Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 68. Mexico Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 69. ROLA Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 70. ROLA Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 71. ROLA Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 72. ROW Liver Disease Diagnostics market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 73. ROW Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 74. ROW Liver Disease Diagnostics market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 75. List of secondary sources, used in the study of global Liver Disease Diagnostics market
  • TABLE 76. List of primary sources, used in the study of global Liver Disease Diagnostics market
  • TABLE 77. Years considered for the study
  • TABLE 78. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Liver Disease Diagnostics market, research methodology
  • FIG 2. Global Liver Disease Diagnostics market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Liver Disease Diagnostics market, key trends 2019
  • FIG 5. Global Liver Disease Diagnostics market, growth prospects 2020-2027
  • FIG 6. Global Liver Disease Diagnostics market, porters 5 force model
  • FIG 7. Global Liver Disease Diagnostics market, pest analysis
  • FIG 8. Global Liver Disease Diagnostics market, value chain analysis
  • FIG 9. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Liver Disease Diagnostics market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Liver Disease Diagnostics market, regional snapshot 2017 & 2027
  • FIG 18. North America Liver Disease Diagnostics market 2017 & 2027 (USD Billion)
  • FIG 19. Europe Liver Disease Diagnostics market 2017 & 2027 (USD Billion)
  • FIG 20. Asia Pacific Liver Disease Diagnostics market 2017 & 2027 (USD Billion)
  • FIG 21. Latin America Liver Disease Diagnostics market 2017 & 2027 (USD Billion)
  • FIG 22. Global Liver Disease Diagnostics market, company market share analysis (2019)
目次

Global Liver Disease Diagnostics Market is valued approximately at USD 29.3 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2020-2027. Liver Disease Diagnostics is the detecting of the cause and extent of liver disease and it further includes the treatment process. It consists of blood tests, imaging tests, checking a tissue sample, treatment method and clinical trials. Factors such as growing geriatric population and rising prevalence of acute and chronic liver diseases will increase the demand for liver disease diagnostic market. For instance, according to the World Health Organization (WHO), the total new cases of liver cancer that were reported in 2018 were 841,080 and an estimated 781, 631 people died due to liver cancer, globally. Moreover, increasing incidences of end stage liver failure due to rising heavy alcohol consumption, growing prevalence of obesity and the metabolic syndrome are some of the major factors which can upsurge the growth of global organ care system for liver. For instance: According to Statista, alcohol consumption in India was 5.4 billion liters in 2016 and is estimated to reach about 6.5 billion liters by 2020. Also, as per Summary Health Statistics, the number of U.S. adults diagnosed with any sort of liver disease was 3.27 million in 2013 and which rose to 4.5 million adults in 2018. However, the stringent government regulations, high cost incurred in drug R&D and side effects associated with medication are some factors restraining the growth of global Liver Disease Diagnostics market during the forecast period.

The regional analysis of global Liver Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the the fast adoption of new technology, high investments in R&D and presence of key players are some factors expected to be responsible for the growth of the market for liver disease diagnostics in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:

Abbott Laboratories

F. Hoffmann-La Roche AG

Randox Laboratories

Boston Scientific Corporation

Siemens Healthineers AG

BioMerieux

Quest Diagnostics

Biosino Bio-technology

Horiba, Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnosis Technique:

Laboratory Tests

Imaging

Endoscopy

Biopsy

Others

By End-Use:

Hospitals

Laboratories

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Liver Disease Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Liver Disease Diagnostics Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Liver Disease Diagnostics Market, by Diagnosis Technique, 2018-2027 (USD Billion)
    • 1.2.3. Liver Disease Diagnostics Market, by End-Use, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Liver Disease Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Liver Disease Diagnostics Market Dynamics

  • 3.1. Liver Disease Diagnostics Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Liver Disease Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Liver Disease Diagnostics Market, by Diagnosis Technique

  • 5.1. Market Snapshot
  • 5.2. Global Liver Disease Diagnostics Market by Diagnosis Technique, Performance - Potential Analysis
  • 5.3. Global Liver Disease Diagnostics Market Estimates & Forecasts by Diagnosis Technique 2017-2027 (USD Billion)
  • 5.4. Liver Disease Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Laboratory Tests
    • 5.4.2. Imaging
    • 5.4.3. Endoscopy
    • 5.4.4. Biopsy
    • 5.4.5. Others

Chapter 6. Global Liver Disease Diagnostics Market, by End-Use

  • 6.1. Market Snapshot
  • 6.2. Global Liver Disease Diagnostics Market by End-Use, Performance - Potential Analysis
  • 6.3. Global Liver Disease Diagnostics Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
  • 6.4. Liver Disease Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Laboratories
    • 6.4.3. Others

Chapter 7. Global Liver Disease Diagnostics Market, Regional Analysis

  • 7.1. Liver Disease Diagnostics Market, Regional Market Snapshot
  • 7.2. North America Liver Disease Diagnostics Market
    • 7.2.1. U.S. Liver Disease Diagnostics Market
      • 7.2.1.1. Diagnosis Technique breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. End-Use breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Liver Disease Diagnostics Market
  • 7.3. Europe Liver Disease Diagnostics Market Snapshot
    • 7.3.1. U.K. Liver Disease Diagnostics Market
    • 7.3.2. Germany Liver Disease Diagnostics Market
    • 7.3.3. France Liver Disease Diagnostics Market
    • 7.3.4. Spain Liver Disease Diagnostics Market
    • 7.3.5. Italy Liver Disease Diagnostics Market
    • 7.3.6. Rest of Europe Liver Disease Diagnostics Market
  • 7.4. Asia-Pacific Liver Disease Diagnostics Market Snapshot
    • 7.4.1. China Liver Disease Diagnostics Market
    • 7.4.2. India Liver Disease Diagnostics Market
    • 7.4.3. Japan Liver Disease Diagnostics Market
    • 7.4.4. Australia Liver Disease Diagnostics Market
    • 7.4.5. South Korea Liver Disease Diagnostics Market
    • 7.4.6. Rest of Asia Pacific Liver Disease Diagnostics Market
  • 7.5. Latin America Liver Disease Diagnostics Market Snapshot
    • 7.5.1. Brazil Liver Disease Diagnostics Market
    • 7.5.2. Mexico Liver Disease Diagnostics Market
  • 7.6. Rest of The World Liver Disease Diagnostics Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Abbott Laboratories
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. F.Hoffmann-La Roche AG
    • 8.2.3. Randox Laboratories
    • 8.2.4. Boston Scientific Corporation
    • 8.2.5. Siemens Healthineers AG
    • 8.2.6. BioMerieux
    • 8.2.7. Quest Diagnostics
    • 8.2.8. Biosino Bio-technology
    • 8.2.9. Horiba, Ltd.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.